Bachchans, Dutts were not present on Vivek’s reception

Vivek-Oberoi-receptionIt looks like Bachchans and Dutts are not prepared to repair fences with Vivek Oberoi as in spite of personal invite from Vivek, the pair didn't turn up for Vivek's reception yesterday in Mumbai.

Fascinatingly, Vivek tried to clarify out the differences with the Bachchans and Dutts, however it seems like it failed. The Bollywood super stars should have attended the marriage to bless the newlywed couple.

Karan Johar suffering with Malaria

Karan-JoharOhh these mosquitoes, they don't spare a person, in any case in this city. At the present, the newest sufferer to fall victim to a mosquito bite is producer-director Karan Johar.

As per the fresh reports, the producer is suffering with high fever which according to the doctors is a occurrence of malaria. Though, details of KJO's sickness are still expected.

Roland Joffé’s Maratha warrior is Bips

She may perhaps have not had an immense hit ever since 'All The Best' last Diwali, but however Bipasha Basu has brushed sideways all competition and catch a big ticket Hollywood film and that is without any try-out. The film in question is City Of Joy director Roland Joffé's subsequent one.

Spectacle, casting Chris Pine (Star Trek - 2009), Josh Hartnett (Pearl Harbor - 2001) and Olga Kurylenko (Quantum Of Solace - 2008). Fascinatingly, the Ajey Jhankar-written film was presented on over 3 years earlier with Brendan Fraser, Vivek Oberoi and Aishwarya Rai Bachchan. This one shall be featuring Abhay Deol.

FSSAI asks for no antibiotics in honey

FSSAI asks for no antibiotics in honey India's FOOD Safety and Standards Authority of India (FSSAI) has issued a directive as per which no residues of antibiotics and pesticide should be found in honey if they are to be sold in Indian market. Such strict measures have been taken since stringent measures have been followed in EU and the US.

15 products suspected of heart diseases banned in China

15 products suspected of heart diseases banned in China   15 products which were made for weight-loss purposes have been banned in China. This has been done since these products said to increase risks related to heart. These products have been banned by the State Food and Drug Administration (SFDA). The report first came in China Daily.

Delhi sees rise in Chikungunya cases

Delhi sees rise in Chikungunya cases The fatal disease of Chikungunya is back in the capital and the health agencies have reported close to 1000 cases in the last 20 days. Said V K Monga, MCD's Public Health Committee Chairman that government records have shown there are 33 cases of Chikungunya.

But when regular talks with the doctors and health centers were carried then it was seen that close to 1000 people have been affected so far. Both the private as well as the public hospitals are getting a large of number of affected patients have been coming on a continuous basis.

Pages

News in Focus

Poonawalla Fincorp Share Price Target at Rs 600: Motilal Oswal Financial Services

Poonawalla Fincorp has established itself as a reliable and easy-to-access financial services provider in the recent years.

AMD Stock Price Declines Over 10% on Hunterbrook Media Report; Selling Pressure Intensifies in Tech Sector

AMD Stock price faced major slide on Wednesday after a report published by market research firm Hunterbrook Media claimed that the company could face scrutiny over hardware sales to China.

Grasim Industries Share Price Target at Rs 4,000: ICICI Securities

ICICI Securities has maintained its BUY call on Grasim Industries with a revised target price of Rs 4,000, down from Rs 4,175, implying about 32% upside from the current market price of Rs 3,034.

Titagarh Rail Systems Share Price Target at Rs 966 ICICI Securities

ICICI Securities has upgraded Titagarh Rail Systems to BUY from ADD and kept its target price at Rs 966, about 31% above the current market price of Rs 737.

Star Cement Share Price Target at Rs 251: ICICI Securities

ICICI Securities has maintained its BUY rating on Star Cement but cut its target price to Rs 229 from Rs 251, still about 30% above the current market price of Rs 176.

VIP Industries Share Price Target at Rs 300: Motilal Oswal Financial Services

Motilal Oswal Financial Services has reiterated its BUY rating on VIP Industries with a revised target price of Rs 300, about 26% above the current market price of Rs 238.